Sort
39,280 grants matching “leukemia”
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
$379,343Stanley R Riddell · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Improved Targeting Strategies
$379,337Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Chemoresistance and Stem Cell Selection
$379,305David A Williams · Boston Children'S Hospital · R01 · FY2008 · DK
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
$379,294Michele S. Redell · Baylor College Of Medicine · R01 · FY2018 · CA
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
$379,294Michele S. Redell · Baylor College Of Medicine · R01 · FY2017 · CA
Genomics of AML Prognosis
$379,292Jatinder K. Lamba · University Of Florida · R01 · FY2023 · CA
Genomics of AML Prognosis
$379,286Jatinder K. Lamba · University Of Florida · R01 · FY2025 · CA
Transcriptional regulation of TAL1/SCL in normal and malignant hematopoiesis
$379,280Suming Huang · University Of Florida · R01 · FY2010 · HL
Safe and Efficient Generation of hES-derived Bone Marrow
$379,271Margaret Goodell · Baylor College Of Medicine · R01 · FY2007 · DK
Combination Gene Therapy and Th1-Th2 Therapy
$379,226Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Understanding T Cell Rapamycin Resistance
$379,226Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Transfusion of Donor Effector Memory T Cells for GVL and Immune Reconstitution
$379,225Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Role of Tissue Antigen Presenting Cells in GVHD
$379,225Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
$379,225Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Investigation of the mechanisms of action of eltrombopag
$379,220Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Transcriptional Elongation Control in Development and Disease
$379,200Ali Shilatifard · Northwestern University At Chicago · R01 · FY2019 · CA
HIGH THROUGHPUT DETECTION OF GENETIC MUTATIONS AS BIOMARKERS OF FUT
$379,191Richard A Mathies · University Of California Berkeley · U54 · FY2008 · ES
Zfx, a novel transcriptional regulator of hematopoiesis
$379,174Boris Reizis · Columbia University Health Sciences · R01 · FY2013 · HL
Targeting Chk1 in Acute Myeloid Leukemia
$379,149Larry M Karnitz · Mayo Clinic Rochester · R01 · FY2015 · CA
C21, a Transcriptional Regulator in Hematopoiesis
$379,125New York University School Of Medicine · R01 · FY2002 · HL
DEREGULATION OF CELLULAR IKB KINASES BY HTLV1 TAX
$379,098Vanderbilt University · R01 · FY2002 · CA
Support For Infrastructure of Childhood Leukemia Environmental Research
$379,057Catherine Metayer · University Of California Berkeley · U24 · FY2024 · ES
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
$379,052Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2024 · CA
MicroRNAs' Role in Hematopoietic Lineage Differentiation
$379,043Chang-Zheng Chen · Stanford University · R01 · FY2009 · HL
DNA Adducts of Styrene and Other Vinyl Monomers
$379,030Michael P Stone · Vanderbilt University · R01 · FY2007 · ES